|Articles|November 1, 1999
Supplements and Featured Publications
- The Clinical and Economic Impact of Pneumococcal Disease in the Pediatric Population
- Volume 5
- Issue 17 Suppl
Prevention of Pneumococcal Disease in High-Risk Pediatric Groups
Author(s)Stephen I. Pelton, MD
Advertisement
Articles in this issue
over 26 years ago
Participating Facultyover 26 years ago
Introductionover 26 years ago
Epidemiology of Pneumococcal Diseaseover 26 years ago
The Costs of Antimicrobial Treatment Failure in Acute Otitis Mediaover 26 years ago
The Clinical Impact of Pneumococcal Conjugate Vaccinesover 26 years ago
Economic Impact of Pneumococcal Conjugate Vaccine in Managed Careover 26 years ago
Into the Era of the Pneumococcal Conjugate Vaccineover 26 years ago
Selected Abstractsover 26 years ago
CME Quizover 26 years ago
BibliographyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
4
Understanding Real-World MRI Utilization for ED Dizziness: Ava L. Liberman, MD
5
